You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 8, 2025

Details for Patent: 3,793,457


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,793,457
Title:Therapeutically active phenylalkane derivatives
Abstract:2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID, 2-(2,2''-FLUORO4-BIPHENYLYL) PROPIONIC ACID AND 2-(2,2''-DIFLUORO-4-BIHENYLYL) PROPIONIC ACID POSSESSING GREAT ANTI-INFLAMMATORY, ANALGESIC, AND ANTIPYRETIC ACTIVITIES.
Inventor(s):S Adams, B Armitage, J Nicholson, A Blancafort
Assignee:Boots Co PLC
Application Number:US00308558A
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 3,793,457

Introduction

United States Patent 3,793,457, titled "Therapeutically Active Phenylalkane Derivatives," was patented on February 19, 1974. This patent is an example of how chemical compounds can be protected under the U.S. patent system. Here, we will delve into the details of the patent, including its scope, claims, and the broader patent landscape.

Overview of the Patent

The patent in question pertains to therapeutically active phenylalkane derivatives. These compounds are described for their anti-inflammatory and potentially other therapeutic activities. The patent outlines the methods of preparation, the chemical structures of the compounds, and the tests conducted to determine their efficacy.

Patent Scope

The scope of a patent is defined by its claims, which are the legally binding descriptions of the invention that the patent protects. Here are some key aspects of the scope:

Claims

The claims in a patent application are crucial as they define the scope of the patent's protection. For US Patent 3,793,457, the claims would typically include:

  • Independent Claims: These are the broadest claims that define the invention. They would cover the general structure of the phenylalkane derivatives and their therapeutic uses.
  • Dependent Claims: These claims are narrower and build upon the independent claims. They might specify particular variations of the compounds, specific methods of preparation, or detailed therapeutic applications[2].

Patentable Subject Matter

To be patentable, an invention must be useful, novel, and non-obvious. The phenylalkane derivatives in this patent must have met these criteria:

  • Usefulness: The compounds must have a tangible benefit, such as anti-inflammatory activity.
  • Novelty: The invention must not be fully anticipated by prior art, meaning it must be new and not previously disclosed.
  • Non-obviousness: The invention must not have been readily within the ordinary skills of a competent artisan at the time it was made[1][2].

Patent Claims Analysis

The analysis of patent claims can provide insights into the patent's scope and strength.

Independent Claim Length and Count

Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Patents with narrower claims, as measured by shorter independent claim length and lower independent claim count, tend to have a higher probability of grant and a shorter examination process. This suggests that the claims in US Patent 3,793,457 would have been scrutinized to ensure they are specific and well-defined, contributing to the patent's validity and enforceability[3].

Patent Examination Process

The examination process for US Patent 3,793,457 would have involved several steps:

Prior Art Search

The patent examiner would have conducted a prior art search to ensure the claimed invention was novel and non-obvious. This involves reviewing existing patents, publications, and other state of the art knowledge to determine if the invention was previously disclosed[2].

Office Actions and Responses

During the examination process, the patent examiner may have issued Office Actions rejecting or objecting to certain claims. The applicant would have had the opportunity to respond to these actions, amend the claims, and argue for the patentability of the invention. This iterative process helps to refine the claims and ensure they meet the statutory requirements for patentability[2].

Patent Landscape

The patent landscape for chemical compounds like those described in US Patent 3,793,457 is complex and dynamic.

Technological Competitiveness

The U.S. patent system plays a crucial role in technological competitiveness. Patents like US 3,793,457 contribute to innovation by providing exclusive rights to the inventor, which can incentivize further research and development in the field of therapeutic compounds[1].

Current Issues and Concerns

The patent landscape is not without challenges. Issues such as patent subject matter eligibility, the quality of patents, and the balance between encouraging innovation and preventing overly broad patents are ongoing concerns. For instance, the debate over patent quality has led to discussions about the breadth and clarity of patent claims, which can impact licensing and litigation costs[1][3].

Key Takeaways

  • Patent Scope Defined by Claims: The claims in a patent define its scope and are crucial for determining what is protected.
  • Patentability Requirements: Inventions must be useful, novel, and non-obvious to be patentable.
  • Examination Process: The patent examination process involves a prior art search and iterative responses to Office Actions to ensure the claims meet statutory requirements.
  • Patent Landscape: The U.S. patent system is vital for technological competitiveness, but it faces challenges related to patent quality and subject matter eligibility.

FAQs

Q: What are the main types of patents granted by the USPTO? A: The USPTO grants utility patents, design patents, and plant patents. Utility patents are the most common and cover new and useful processes, machines, articles of manufacture, or compositions of matter[2].

Q: How long does a patent term last in the United States? A: A patent term generally lasts for 20 years from the date the patent application was filed[2].

Q: What is the role of the claims in a patent application? A: The claims define the scope of the patent's protection and are essential for determining what is protected by the patent[2].

Q: What is a prior art search in the context of patent examination? A: A prior art search involves reviewing existing patents, publications, and other state of the art knowledge to determine if the claimed invention is novel and non-obvious[2].

Q: Can an inventor file a patent application without the help of a patent attorney? A: Yes, an inventor can file a patent application on their own behalf (pro se) or hire a registered patent attorney or patent agent to assist them[2].

Sources

  1. Congressional Research Service, "Patents and Innovation Policy," June 25, 2022.
  2. The Maryland People's Law Library, "Patents."
  3. SSRN, "Patent Claims and Patent Scope," September 29, 2016.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 3,793,457

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 3,793,457

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Belgium 658723 ⤷  Try for Free
Switzerland 454822 ⤷  Try for Free
Switzerland 501577 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.